Literature DB >> 26595282

(1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.

Qian-Yun Niu1, Zhen-Yu Li2, Guan-Hua Du3, Xue-Mei Qin4.   

Abstract

Doxorubicin (DOX) is used as a chemotherapy drug with severe carditoxicity. In this study, an integrated echocardiography along with pathological examination and (1)H NMR analysis of multiple biological matrices (urine, serum, heart, and kidney) was employed to systemically assess the toxicity of DOX. Echocardiographic results showed that impaired left ventricular contractility and degenerative pathology lesions in DOX group, which were in consistent with pathology. The endogenous metabolites in the urine, serum, heart and kidney was identified by comparison with the data from the literature and databases. Multivariate analysis, including PCA and OPLS, revealed 8 metabolites in urine, including succinate, 2-ketoglutarate, citrate, hippurate, methylamine, benzoate, allantion, and acetate were the potential changed biomarkers. In serum, perturbed metabolites include elevation of leucine, β-glucose, O-acetyl-glycoprotein, creatine, lysine, glycerin, dimethylglycine, trimethylamine-N-oxide, myo-inositol, and N-acetyl-glycoprotein, together with level decreases of acetone, lipid, lactate, glutamate, phosphocholine, acetoacetate and pyruvate. For heart, DOX exposure caused decline of lipid, lactate, leucine, alanine, glutamate, choline, xanthine, glycerin, carnitine, and fumarate, together with elevation of glutamine, creatine, inosine, taurine and malate. Metabolic changes of kidney were mainly involved in the accumulation of α-glucose, lactate, phosphocholine, betaine, threonine, choline, taurine, glycine, urea, hypoxanthine, glutamate, and nicotinamide, coupled with reduction of asparagine, valine, methionine, tyrosine, lysine, alanine, leucine, ornithine, creatine, lipid, and acetate. In addition, alterations of urinary metabolites exhibited a time-dependent manner. Complementary evidences by multiple matrices revealed disturbed pathways concerning energy metabolism, fatty acids oxidation, amino acids and purine metabolism, choline metabolism, and gut microbiota-related metabolism. In addition, the change of endogenous metabolites in rats urine, serum, heart and kidney were correlated with the echocardiography parameters. This integrative study should help to develop a systematic understanding of cardiomyopathy-related diseases and their metabolic events.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Doxorubicin; Metabolomic; Multivariate data analysis; NMR; Rats; Toxicity

Mesh:

Substances:

Year:  2015        PMID: 26595282     DOI: 10.1016/j.jpba.2015.10.026

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  15 in total

1.  Serum lipidomics in diagnostics of sarcoidosis.

Authors:  Beata Toczylowska; Dariusz Jastrzebski; Sabina Kostorz; Elzbieta Zieminska; Dariusz Ziora
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice.

Authors:  Diego Dos Santos Ferreira; Bruno Luís Jesus de Oliveira Pinto; Vidhya Kumar; Valbert Nascimento Cardoso; Simone Odília Fernandes; Cristina Maria Souza; Geovanni Dantas Cassali; Anna Moore; David E Sosnovik; Christian T Farrar; Elaine Amaral Leite; Ricardo José Alves; Mônica Cristina de Oliveira; Alexander Ramos Guimarães; Peter Caravan
Journal:  Nanomedicine       Date:  2017-03-23       Impact factor: 5.307

Review 3.  Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.

Authors:  Leonardo Schirone; Luca D'Ambrosio; Maurizio Forte; Riccardo Genovese; Sonia Schiavon; Giulia Spinosa; Giuliano Iacovone; Valentina Valenti; Giacomo Frati; Sebastiano Sciarretta
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

4.  A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.

Authors:  Jessica A Palmer; Alan M Smith; Vitalina Gryshkova; Elizabeth L R Donley; Jean-Pierre Valentin; Robert E Burrier
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

5.  Untargeted metabolomics approach for unraveling robust biomarkers of nutritional status in fasted gilthead sea bream (Sparus aurata).

Authors:  Ruben Gil-Solsona; Jaime Nácher-Mestre; Leticia Lacalle-Bergeron; Juan Vicente Sancho; Josep Alvar Calduch-Giner; Félix Hernández; Jaume Pérez-Sánchez
Journal:  PeerJ       Date:  2017-01-26       Impact factor: 2.984

6.  Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.

Authors:  Sibu P Kuruvilla; Gopinath Tiruchinapally; A Colleen Crouch; Mohamed E H ElSayed; Joan M Greve
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

7.  1H NMR-based Investigation of Metabolic Response to Electro-Acupuncture Stimulation.

Authors:  Caigui Lin; Zhiliang Wei; Kian-Kai Cheng; Jingjing Xu; Guiping Shen; Chang She; Huan Zhong; Xiaorong Chang; Jiyang Dong
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

8.  Dynamic observation and analysis of metabolic response to moxibustion stimulation on ethanol-induced gastric mucosal lesions (GML) rats.

Authors:  Miao-Sen Huang; Yuan Zhang; Cai-Chun Liu; Lin-Yu Lian; Jia-Cheng Shen; Qi-da He; Ying-Jie Wang; Long-Bin Zhang; Mi Liu; Zong-Bao Yang
Journal:  Chin Med       Date:  2019-10-15       Impact factor: 5.455

9.  Kidney Tissue Targeted Metabolic Profiling of Unilateral Ureteral Obstruction Rats by NMR.

Authors:  Zhenyu Li; Aiping Li; Jining Gao; Hong Li; Xuemei Qin
Journal:  Front Pharmacol       Date:  2016-09-15       Impact factor: 5.810

10.  New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro 1H-NMR Metabonomics.

Authors:  Matthieu Dallons; Corentin Schepkens; Aurélie Dupuis; Vanessa Tagliatti; Jean-Marie Colet
Journal:  Front Pharmacol       Date:  2020-02-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.